On 25 July 1978, Louise Brown was born in Oldham, England — the first person conceived outside a mother’s body. Five years later, in Melbourne, a girl was born from someone else’s egg. This was a different threshold: not just a technique, but a question about who the “real” mother is.
The path to egg donation was long. In 1890, British embryologist Walter Heape successfully transferred embryos from one rabbit to another. In 1948, John Rock and Miriam Menkin fertilised 138 human eggs outside the body — the first human embryos in vitro in history. None survived, but the protocols were established.
Louise Brown’s birth in 1978 opened the era of IVF. But egg donation required something more: the ability to work with another woman’s egg and synchronise two female cycles simultaneously. Alan Trounson’s team at Monash IVF in Melbourne solved this. In 1983, a healthy girl was born to a woman without ovaries — from a donor egg.
A year later, on 3 February 1984, the first donor-egg baby was born in Southern California. Since then, global statistics have accumulated more than 500,000 such births. The technology became routine. The questions about it did not.
Egg donation is a physically far more demanding procedure than sperm donation. The donor undergoes hormonal stimulation (10 to 14 days of injections), regular ultrasound monitoring, and then transvaginal aspiration under sedation. Several weeks, several appointments, real medical risks. The question of motivation is therefore sharper here.
According to a large ESHRE survey: 47.8 percent of European donors cite “pure altruism” as their primary motive. Around 33.9 percent give a mixed motive: both wanting to help and receiving compensation. Around 10.8 percent are primarily financially motivated.
In the United States, around 40 percent of egg donors are university students. Average payment: $4,000 per cycle. This is neither good nor bad — but it is a fact that changes the conversation about “altruism.”
The difference between the European and American models is fundamental. In the EU, donors are reimbursed for actual expenses: in Spain €800–1,000, in the UK up to £750 per cycle. In the US there is no federal cap: donors receive $8,000–15,000 per cycle, and some agencies offer bonuses for “in-demand” characteristics — education, athletic achievement, IQ. Whether this is fair compensation or the commercialisation of the body is one of the most unresolved ethical questions in reproductive medicine.
Best practice: the donor receives full information before deciding, has a minimum of seven days to reflect, and can withdraw consent at any point before the aspiration. Studies show that around a third of donors, after receiving complete information, change their conditions or withdraw. This is not a system failure — it is the system working.
The mandatory minimum in the EU: an infectious disease panel (HIV, Hepatitis B and C, syphilis), karyotype, hormonal profile (AMH, FSH, LH, TSH), antral follicle count by ultrasound. Mandatory: testing for cystic fibrosis (CFTR) and fragile X syndrome (FMR1). In leading clinics: extended carrier screening (ECS) covering 300+ genes.
The United Kingdom abolished anonymity in 2005: children born from donor eggs may request the donor’s personal details upon turning 18. Sweden, the Netherlands and Austria have done the same. Spain retains anonymity. Germany and Italy effectively prohibit egg donation, which drives couples abroad.
DNA tests are making legal anonymity increasingly unrealistic: children from anonymous donors find biological mothers through AncestryDNA and 23andMe regardless of what any contract says. Several clinics have already moved to an open-donor model in response to this trend.
ESHRE recommendations: no more than six cycles for a single donor in total, given the medical burden. On the number of families: most European countries apply a limit of five to ten families per donor, though there is no single binding standard.
UK standard: a mandatory session with an independent psychologist before and after the process. In the US: at the clinic’s discretion. The difference is real: some donors later report mixed feelings — pride, curiosity about the “biological” children, sometimes regret. This is not pathology, but it needs space for conversation.
Mandatory EU Tissues and Cells Directive certification in the EU, HFEA licence in the UK, SART/CAP accreditation in the US. Questions worth asking the clinic: what accreditation does it hold, what genetic screening is used for donors, what is the family limit per donor, what is the anonymity policy, and is psychological support provided to the donor.
Hormonal stimulation: 10 to 14 days of daily FSH injections. Ultrasound monitoring every 2 to 3 days. A “trigger” injection 36 hours before aspiration — and the aspiration itself under sedation, 15 to 20 minutes.
Short-term side effects — bloating, abdominal discomfort, mood changes — are common and resolve quickly. The main serious risk: OHSS (ovarian hyperstimulation syndrome). Mild forms occur in 10 to 20 percent of donors. Severe cases requiring hospitalisation: less than one percent.
No long-term data demonstrate a significant negative impact on the donor’s future fertility — but long-term studies are also insufficient. This is the honest position every clinic is obliged to take.
“Egg donation is a relatively safe procedure. But ‘relatively’ is the operative word” — most reproductive specialists would agree with this.
A large Australian study in 2015 found that more than 80 percent of adults conceived through donor programmes supported the right to access information about their donor. Not necessarily to establish a relationship — but to know.
Three models exist today:
This choice must be made before the procedure begins. After conception it cannot legally be changed.
Donor genetic screening: which panel? Does it include ECS, karyotype, FMR1?
How many families have already used this donor’s material? Is there a limit and how is it tracked?
Anonymity model: what does the clinic offer? What if the child wants to know about the donor at 18?
Psychological support: is it provided to the donor? To you?
Clinic accreditation: to what standard and when was the last inspection?
Egg donation has travelled in forty years from an experimental procedure to a routine practice that has changed the lives of hundreds of thousands of families. Ethics did not keep pace with technology — and in some areas still has not: anonymity undone by DNA tests, compensation that turns donation into a market, the rights of the child that are often forgotten in conversations about the rights of donor and recipient.
It is precisely these questions that make egg donation not just a medical procedure, but a conversation about what it means to become a parent — and what we pass to a child biologically, legally and ethically.
The first girl born from a donor egg grew up. Whether she knows about her origins has never been publicly discussed. Perhaps that itself is an answer to something important.
Module 2 (Donor Selection & Genetics) contains a full checklist for assessing egg donor screening. Verified ART clinics working to international standards are available in the Partners section.
OHSS (ovarian hyperstimulation syndrome) — a complication of hormonal stimulation in which the ovaries overrespond. Mild forms: discomfort and bloating. Severe cases (< 1%) require hospitalisation.
ECS (Extended Carrier Screening) — testing for carrier status of 300+ autosomal recessive conditions. Identifies potential overlapping mutations between donor and recipient before conception.
Identity-release donor — a donor who has agreed to disclosure of their personal details to the child upon reaching adulthood. Standard in the UK, the Netherlands and Sweden.
Egg sharing — a programme in which a woman undergoing her own IVF cycle donates a portion of her retrieved eggs to another recipient in exchange for a reduction in the cost of her own treatment.
POI (Primary Ovarian Insufficiency) — premature loss of normal ovarian function before age 40. One of the primary medical indications for using donor eggs.
Join thousands building families on their own terms.
Browse Profiles